Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Livent is a specialty chemicals business based in the US. Livent shares (LTHM) are listed on the NYSE and all prices are listed in US Dollars. Livent employs 1,100 staff and has a trailing 12-month revenue of around $716.7 million.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $26.73 |
|---|---|
| 52-week range | $18.26 - $36.38 |
| 50-day moving average | $23.93 |
| 200-day moving average | $26.73 |
| Wall St. target price | $32.25 |
| PE ratio | 26.1 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.00 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $26.73 from 2023-02-02
| 1 week (2023-01-27) | 2.57% |
|---|---|
| 1 month (2023-01-03) | 40.83% |
| 3 months (2022-11-03) | -9.08% |
| 6 months (2022-08-02) | 3.09% |
| 1 year (2022-02-04) | 20.13% |
|---|---|
| 2 years (2021-02-04) | 33.72% |
| 3 years (2020-02-04) | 138.66% |
| 5 years (2018-01-31) | N/A |
Valuing Livent stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Livent's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Livent's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Livent shares trade at around 26x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Livent's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.1545. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Livent's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Livent's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $286 million.
The EBITDA is a measure of a Livent's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $716.7 million |
|---|---|
| Operating margin TTM | 36.31% |
| Gross profit TTM | $93.6 million |
| Return on assets TTM | 10.3% |
| Return on equity TTM | 18.54% |
| Profit margin | 27.67% |
| Book value | $7.55 |
| Market capitalisation | $4.7 billion |
TTM: trailing 12 months
We're not expecting Livent to pay a dividend over the next 12 months.
Over the last 12 months, Livent's shares have ranged in value from as little as $18.26 up to $36.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Livent's is 1.7602. This would suggest that Livent's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania. .
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.